Conservatives accused ABC News host George Stephanopoulos of 'gaslighting' the public after it was revealed he privately described President Joe Biden's condition as 'heartbreaking up close ...

In 2025, Sony is mixing the old with the new. On one hand, Sony is adding three new TVs to its catalog for 2025. But it's also bringing the rest of its range from last year, too. The brand new ...

Trader Joe's mini tote bags are back stores, but you'll need to act fast if you'll want to get one of the year's hottest accessories for yourself. Lines stretched around the block around the ...

In early April, the grocery store dropped the mini bags in pastel shades of pink, blue, green and purple Trader Joe's Trader Joe’s highly sought-after mini tote has returned to shelves, but with ...

Lilly, which makes the once-monthly anti-amyloid infusion donanemab (Kisunla), announced in late March that patients would be able to quickly access a neurologist for diagnosis via its telehealth ...

Secondary outcomes were score changes from baseline to week 52 in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), Mini-Mental State Examination, Alzheimer's Disease Cooperative ...

Trader Joe's beloved mini totes are back in a slate of new colors just in time for spring. The California-based grocery store chain confirmed to USA TODAY last month it would release its mini ...

Later this year, Rafii and the ATRI team will initiate the ALADDIN trial, which will investigate the use of donanemab in people with Down syndrome. Donanemab is already FDA-approved for Alzheimer ...

Researchers at The Ohio State University Wexner Medical Center and College of Medicine have discovered a new way that neurons act in neurodegeneration by using human neural organoids – also know ...

Lawyers contend a former Bolingbrook police sergeant’s mental state seems to have deteriorated further since last year as they deal with his bid to vacate his murder conviction. Attorneys with ...

Ebglyss and Kisunla (donanemab). Lilly expects its new drugs, Mounjaro, Zepbound, Omvoh, Jaypirca, Ebglyss and Kisunla, along with the expanded use of existing drugs, to drive sales growth in 2025.